BSE filing, NSE: AGARWALEYE. Summary written from the filing by ALFA Finder's alert engine.
Dr. Agarwals Health Care Ltd: key numbers
- Share price
- ₹509.20
- Market cap
- ₹16,143 Cr
- Revenue (annual)
- ₹2,080 Cr
- Net profit (annual)
- ₹133.2 Cr
- P/E (TTM)
- 108.8×Sector 52.8×
- Promoter holding
- 32.33%-0.01% QoQ
- FII holding
- 49.56%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Agarwals Health Care Ltd
All →Dr. Agarwals Health Care Board Meeting Date
Dr. Agarwal's Health Care schedules a board meeting on November 5, 2026 to consider Q2 results. An earnings call follows at 6:30 PM IST that day.
Dr. Agarwals Health Care Merger & Restructuring Worth ₹711.2 Cr
Dr. Agarwals Health Care Limited has completed the merger of Dr. Agarwal's Eye Hospital Limited into itself for a total transaction value of ₹711.21 Crore.
- Value
- ₹711.2 Cr
Dr. Agarwals Health Care Employee Stock Options
Dr. Agarwal's Health Care Limited allotted 18,200 equity shares upon the exercise of vested ESOPs. The transaction is valued at approximately ₹0.24 Crore.
- Value
- ₹0.24 Cr
Dr. Agarwals Health Care Acquisition
The amalgamation scheme between Dr. Agarwal's Health Care and Dr. Agarwal's Eye Hospital is effective from November 01, 2026. The Record Date is November 18, 2026.
Dr. Agarwals Health Care Other Announcement
Dr. Agarwals Health Care Ltd has submitted its quarterly shareholding pattern statement for the quarter ended September 30, 2026, pursuant to SEBI Regulation 31(1)(b).
Dr. Agarwals Health Care Merger & Restructuring Worth ₹0.73 Cr
Dr. Agarwal's Health Care Ltd. completed the acquisition of its Nigeria-based step-down wholly owned subsidiary, previously announced on August 4, 2026, for ₹0.73 Crore.
- Value
- ₹0.73 Cr
Other credit rating announcements
All →Mangalam Global Enterprise Credit Rating
Infomerics reaffirmed Mangalam Global's IVR BBB rating, revised outlook to Negative and moved it to Issuer Not Cooperating. Rating action dated 29 October 2026.
DCM Shriram Credit Rating
DCM Shriram reaffirmed ICRA ratings on its long-term and short-term bank facilities and fixed deposit programme. Commercial paper rating was reaffirmed and withdrawn, with no change in rating levels.
Oil And Natural Gas Corporation Credit Rating
ONGC's debt instruments were affirmed at IND AAA/Stable by India Ratings. The affirmation covers bank loans, commercial papers and non-convertible debentures.
Regency Fincorp Credit Rating
Infomerics reaffirmed Regency Fincorp's IVR BBB/Stable rating on its NCDs and bank facilities. The rating covers Rs 650 Crore of instruments and is valid until July 16, 2027.
Borosil Renewables Credit Rating
Borosil Renewables had its bank loan rating upgraded to IND AA-/Stable/IND A1+ by India Ratings. Proposed bank facilities of Rs 450 million were assigned the same rating.
Singer India Credit Rating
Singer India's Rs.45 Crore bank facilities were re-rated by CRISIL. Long-term stayed BBB-/Stable while the short-term rating was upgraded to Crisil A3+.